NCT03255668View on ClinicalTrials.gov

Hematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic Leukemia

CompletedOBSERVATIONAL
Enrollment

106

Participants

Timeline

Start Date

July 25, 2017

Primary Completion Date

October 15, 2018

Study Completion Date

November 1, 2018

Conditions
Mercaptopurine Adverse ReactionLeukemia, Lymphoblastic
Trial Locations (1)

10430

Cipto Mangunkusomo hospital, Jakarta Pusat

All Listed Sponsors
lead

Indonesia University

OTHER

NCT03255668 - Hematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter